WO2004083165A1 - Verfahren zur hertellung von 2-cyan-3-hydroxy-n-(phenyl)but-2-enamiden - Google Patents
Verfahren zur hertellung von 2-cyan-3-hydroxy-n-(phenyl)but-2-enamiden Download PDFInfo
- Publication number
- WO2004083165A1 WO2004083165A1 PCT/EP2004/002311 EP2004002311W WO2004083165A1 WO 2004083165 A1 WO2004083165 A1 WO 2004083165A1 EP 2004002311 W EP2004002311 W EP 2004002311W WO 2004083165 A1 WO2004083165 A1 WO 2004083165A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compound
- phenyl
- formula
- moles
- hydroxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C253/00—Preparation of carboxylic acid nitriles
- C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C253/00—Preparation of carboxylic acid nitriles
- C07C253/32—Separation; Purification; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/24—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton
- C07C255/26—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton containing cyano groups, amino groups and singly-bound oxygen atoms bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/24—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton
- C07C255/27—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton containing cyano groups, amino groups and doubly-bound oxygen atoms bound to the carbon skeleton
Definitions
- the invention relates to a process for the preparation of 2-cyano-3-hydroxy-N- (phenyl) but-2-enamides from 2-cyano-N- (phenyl) acetamide, in particular the preparation of 2-cyano-3-hydroxy N - [(4-trifluoromethyl) -phenyl] but-2-enamide from 2-cyano-N- (4-trifluoromethyl-phenyl) -acetamide.
- 2-cyano-3-hydroxy-N- [phenyl] but-2-enamides can be prepared from 2-cyano-N- (phenyl) acetamide in the presence of acetic anhydride and sodium hydroxide.
- the invention therefore relates to a process for obtaining the compound of the formula I.
- R1 is a) -CF3, b) -0-CF 3, c) -S-CF 3, d) -OH, e) -N0 2 f) halo, g) benzyl, h) phenyl, i) -O-phenyl, k) -CN,
- R 2 represents a) - (C 1 -C 4 ) -alkyl, b) halogen or c) represents a hydrogen atom,
- R1 and R2 are as defined above, in the presence of at least one base, reacting acetic anhydride and at least one solvent and then isolating the compound of formula I formed.
- the invention further relates to a process for obtaining the compound of formula III
- the procedure is such that initially the compound of the formula II or (2-cyano-N- (4-trifluoromethyl-phenyl) -acetamide) is introduced into a solvent and the resulting solution or suspension is cooled , Thereafter, the addition of aqueous sodium hydroxide and acetic anhydride and the resulting reaction mixture is stirred or shaken with cooling.
- the compound of formula I is precipitated with an acid.
- the isolation of the compound of formula I is carried out for example by crystallization or extraction, for example with ethyl acetate or toluene.
- the crystallization is promoted by cooling the suspension or further evaporating the solvents.
- solvent are, for example, water, organic solvents, for example: ketonic solvents such as acetone, methyl ethyl ketone or methyl isobutyl ketone; halogenated hydrocarbons such as dichloromethane;
- Alcohols such as ethanol, isopropanol or n-butanol;
- Ethers such as diisopropyl ether, diethoxymethane or diethylene glycol dimethyl ether;
- Hydrocarbons such as toluene; Esters, such as ethyl acetate; aprotic solvents such as dimethylformamide, dimethylacetamide, dimethyl sulfoxide or N-ethylpyrrolidinone or
- Phase transfer catalysts such as quaternary ammonium or phosphonium salts, for example dimethylditetradecylammonium bromide, benzyltriethylammonium chloride, Alliquat ® 336 (3-methyltrioctylammonium chloride), tetrabutylammonium hydrogen sulfate, or tetrabutylphosphonium chloride;
- bases is understood as meaning alkali metal hydroxides, for example sodium hydroxide or potassium hydroxide, caustic soda in solid form or in the form of alkalis of different concentrations, alkali metal hydrides and alkaline earth metal hydrides, for example sodium hydride, calcium hydride, amides, for example sodium amide, alcoholates, for example sodium methoxide, potassium tert-butoxide.
- organometallic compounds for example n-butyllithium, or amines, for example diethylisopropylamine, or mixtures of the abovementioned inorganic bases
- halogen refers to fluorine, chlorine, bromine and iodine understood.
- - (C-j-C / jJ-alkyl are hydrocarbon radicals such as methyl, ethyl, propyl, n-butyl or
- Suitable acids are, for example, hydrochloric acid, sulfuric acid, nitric acid or phosphoric acid or mixtures of the acids.
- the amount of solvent used is generally from 3 kg to 11 kg per kg of the compound of the formula II or IV, preferably from 4 kg to 6 kg.
- the reaction time is generally between a few minutes and 24 hours, preferably 1 to 3 hours, depending on the composition of the mixture and the selected temperature range.
- the reaction temperature is from -5 ° C to 50 ° C, preferably from 0 ° C to 30 ° C, especially 10 ° C.
- the residual content of the starting substrate of the compound of the formula II or 2-cyano-N- (4-trifluoromethyl-phenyl) -acetamide could be determined in isolated 2-cyano-3-hydroxy-N - [(4-trifluoromethyl) -phenyl] but-2-one. enamide are reduced below a level of 0.5%.
- the starting material for the reaction according to the invention can be prepared by processes known from the literature, for example DE 1 900947.
- the process product is biologically active and is suitable, for example, for the treatment of rheumatoid arthritis or multiple sclerosis.
- Advantageous in the process according to the invention are the very short reaction times, the omission of additional purification steps, the high yields and the high purity of the product produced.
- Advantage of the method according to the invention is the substantially complete reaction to the compound of formula I or 2-cyano-3-hydroxy-N - [(4-trifluoromethyl) phenyl] but-2-enamide and a total by-product content of less than 1%.
- Triethylamine Adjust 5 mL with H 3 P0 4 85% to pH 6.0 5
- Test solution Dissolve 12.5 mg of the substance in acetonitrile R to 25 mL.
- FN ' peak area of the respective by-product in the chromatogram of the test solution
- ⁇ F sum of all peak areas in the chromatogram of the test solution except for the injection peak
- PTC phase transfer catalyst
- Example 9 In a 200 ml four-necked flask, 9.1 g of 2-cyano-N- (4-trifluoromethyl-phenyl) acetamide were weighed and then suspended by addition of 49 ml of methyl isobutyl ketone (slightly yellow thin suspension), which was then cooled to 10 ° C. At this temperature, 17.8 ml of 33% NaOH was added directly from the graduated cylinder. The temperature rose to 12 ° C and there was a difficult to stir kremepme suspension. This was vigorously stirred for 10 minutes. Thereafter, 9.7 ml of acetic anhydride are added dropwise at 7 to 12 ° C within 1 h and 20 min.
- the mixture was stirred for 50 minutes and cooled to 3 to 5 ° C. Then 11.5 ml of water were added dropwise within 10 min at this temperature, the mixture had a pH of 7.1. Subsequently, 16 ml of 37% HCl were added dropwise within 1 h, so that at a constant temperature, a pH of 1.1 was reached. After further stirring for 25 minutes, the pH was still at 1.1 (cream-colored, non-homogeneous stirrable suspension, already after about 7 ml of HCl). Within the next 20 minutes, 47.5 ml of water were added dropwise, the temperature rising to 10 ° C. The pH rose to 1.7. The mixture was then stirred for 40 min.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Priority Applications (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SI200431463T SI1606246T1 (sl) | 2003-03-18 | 2004-03-06 | Postopek za pripravo 2-cian-3-hidroksi-N-(fenil)but-2-enamidov |
| PL04718192T PL1606246T3 (pl) | 2003-03-18 | 2004-03-06 | Sposób wytwarzania 2-cyjano-3-hydroksy-N-(fenylo)but-2-enamidów |
| EP04718192A EP1606246B1 (de) | 2003-03-18 | 2004-03-06 | Verfahren zur hertellung von 2-cyan-3-hydroxy-n-(phenyl)but-2-enamiden |
| DE502004011176T DE502004011176D1 (de) | 2003-03-18 | 2004-03-06 | Verfahren zur hertellung von 2-cyan-3-hydroxy-n-(phenyl)but-2-enamiden |
| HK06106890.2A HK1086818B (en) | 2003-03-18 | 2004-03-06 | Method for producing 2-cyan-3-hydroxy-n-(phenyl)but-2-ene amides |
| DK04718192.0T DK1606246T3 (da) | 2003-03-18 | 2004-03-06 | Fremgangsmåde til fremstilling af 2-cyan-3-hydroxy-N-(phenyl)but-2-enamider |
| AU2004222139A AU2004222139B2 (en) | 2003-03-18 | 2004-03-06 | Method for producing 2-cyan-3-hydroxy-N-(phenyl)but-2-ene amides |
| CA2519209A CA2519209C (en) | 2003-03-18 | 2004-03-06 | Method for producing 2-cyano-3-hydroxy-n(phenyl)but-2-enamides |
| JP2006504568A JP4546952B2 (ja) | 2003-03-18 | 2004-03-06 | 2−シアノ−3−ヒドロキシ−n−(フェニル)ブタ−2−エンアミドの製法 |
| KR1020057017413A KR101072237B1 (ko) | 2003-03-18 | 2004-03-06 | 2-시아노-3-하이드록시-n-(페닐)부트-2-엔 아미드의제조방법 |
| MXPA05009764A MXPA05009764A (es) | 2003-03-18 | 2004-03-06 | Metodo para producir 2-ciano-3-hidroxi-n-(fenil)but-2-enamidas. |
| AT04718192T ATE468323T1 (de) | 2003-03-18 | 2004-03-06 | Verfahren zur hertellung von 2-cyan-3-hydroxy-n- (phenyl)but-2-enamiden |
| IL170934A IL170934A (en) | 2003-03-18 | 2005-09-18 | Method for producing 2-cyan-3-hydroxy-n-(phenyl)but-2-ene amides |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10311763A DE10311763A1 (de) | 2003-03-18 | 2003-03-18 | Verfahren zur Herstellung von 2-Cyan-3-hydroxy-N-(phenyl)but-2-enamiden |
| DE10311763.6 | 2003-03-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2004083165A1 true WO2004083165A1 (de) | 2004-09-30 |
Family
ID=32945937
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/EP2004/002311 Ceased WO2004083165A1 (de) | 2003-03-18 | 2004-03-06 | Verfahren zur hertellung von 2-cyan-3-hydroxy-n-(phenyl)but-2-enamiden |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1606246B1 (https=) |
| JP (1) | JP4546952B2 (https=) |
| KR (1) | KR101072237B1 (https=) |
| CN (1) | CN100361967C (https=) |
| AR (1) | AR043624A1 (https=) |
| AT (1) | ATE468323T1 (https=) |
| AU (1) | AU2004222139B2 (https=) |
| CA (1) | CA2519209C (https=) |
| CY (1) | CY1110722T1 (https=) |
| DE (2) | DE10311763A1 (https=) |
| DK (1) | DK1606246T3 (https=) |
| ES (1) | ES2346215T3 (https=) |
| IL (1) | IL170934A (https=) |
| MX (1) | MXPA05009764A (https=) |
| PL (1) | PL1606246T3 (https=) |
| PT (1) | PT1606246E (https=) |
| RU (1) | RU2330838C2 (https=) |
| SI (1) | SI1606246T1 (https=) |
| TW (1) | TW200503995A (https=) |
| WO (1) | WO2004083165A1 (https=) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009147624A3 (en) * | 2008-06-05 | 2010-12-09 | Alembic Limited | A process for preparing teriflunomide |
| WO2013113037A1 (en) * | 2012-01-28 | 2013-08-01 | Optmed, Inc. | Improved 1, 1-disubstituted ethylene process |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104995166A (zh) * | 2013-01-29 | 2015-10-21 | Opt迈德有限公司 | 改进的1,1-二取代的乙烯方法 |
| CN104693070A (zh) * | 2013-12-10 | 2015-06-10 | 深圳翰宇药业股份有限公司 | 一种特立氟胺的合成方法 |
| CN105272882B (zh) * | 2014-07-23 | 2019-05-31 | 欣凯医药化工中间体(上海)有限公司 | 一种环保简便制备泰瑞米特的方法 |
| CN116924937A (zh) * | 2022-04-02 | 2023-10-24 | 江苏康缘药业股份有限公司 | 2-氰基-3-羟基-2-丁烯-(4-三氟甲基-苯基)酰胺制备方法 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0257882A1 (en) * | 1986-08-08 | 1988-03-02 | Lilly Industries Limited | N-Phenyl butenamides with pharmaceutical properties |
| US5519042A (en) * | 1994-01-13 | 1996-05-21 | Hoechst Aktiengesellschaft | Method of treating hyperproliferative vascular disease |
| US5700822A (en) * | 1994-01-07 | 1997-12-23 | The Regents Of The University Of California | Treatment of platelet derived growth factor related disorders such as cancers |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19636974A1 (de) * | 1996-09-12 | 1998-03-19 | Hoechst Ag | 2-Cyano-3,5-dihydroxy-hex-2-en- carbonsäureamidderivate |
| WO2002034251A1 (en) * | 2000-10-20 | 2002-05-02 | Parker Hughes Institute | Treatment of asthma with lfm analogues |
-
2003
- 2003-03-18 DE DE10311763A patent/DE10311763A1/de not_active Withdrawn
-
2004
- 2004-03-06 JP JP2006504568A patent/JP4546952B2/ja not_active Expired - Lifetime
- 2004-03-06 WO PCT/EP2004/002311 patent/WO2004083165A1/de not_active Ceased
- 2004-03-06 DK DK04718192.0T patent/DK1606246T3/da active
- 2004-03-06 RU RU2005132162/04A patent/RU2330838C2/ru active
- 2004-03-06 AT AT04718192T patent/ATE468323T1/de active
- 2004-03-06 EP EP04718192A patent/EP1606246B1/de not_active Expired - Lifetime
- 2004-03-06 DE DE502004011176T patent/DE502004011176D1/de not_active Expired - Lifetime
- 2004-03-06 MX MXPA05009764A patent/MXPA05009764A/es active IP Right Grant
- 2004-03-06 CA CA2519209A patent/CA2519209C/en not_active Expired - Fee Related
- 2004-03-06 SI SI200431463T patent/SI1606246T1/sl unknown
- 2004-03-06 PL PL04718192T patent/PL1606246T3/pl unknown
- 2004-03-06 KR KR1020057017413A patent/KR101072237B1/ko not_active Expired - Lifetime
- 2004-03-06 ES ES04718192T patent/ES2346215T3/es not_active Expired - Lifetime
- 2004-03-06 AU AU2004222139A patent/AU2004222139B2/en not_active Expired
- 2004-03-06 PT PT04718192T patent/PT1606246E/pt unknown
- 2004-03-06 CN CNB2004800058365A patent/CN100361967C/zh not_active Expired - Lifetime
- 2004-03-16 TW TW093106897A patent/TW200503995A/zh unknown
- 2004-03-16 AR ARP040100868A patent/AR043624A1/es unknown
-
2005
- 2005-09-18 IL IL170934A patent/IL170934A/en active IP Right Grant
-
2010
- 2010-08-03 CY CY20101100723T patent/CY1110722T1/el unknown
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0257882A1 (en) * | 1986-08-08 | 1988-03-02 | Lilly Industries Limited | N-Phenyl butenamides with pharmaceutical properties |
| US5700822A (en) * | 1994-01-07 | 1997-12-23 | The Regents Of The University Of California | Treatment of platelet derived growth factor related disorders such as cancers |
| US5519042A (en) * | 1994-01-13 | 1996-05-21 | Hoechst Aktiengesellschaft | Method of treating hyperproliferative vascular disease |
Non-Patent Citations (1)
| Title |
|---|
| SUTAPA GHOSH ET AL: "Three leflunomide analogs", ACTA CRYSTALLOGR. SECT. C CRYST. STRUCT. COMMUN., vol. 56, no. 10, 2000, pages 1254 - 1257, XP002959255 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009147624A3 (en) * | 2008-06-05 | 2010-12-09 | Alembic Limited | A process for preparing teriflunomide |
| US8389757B2 (en) | 2008-06-05 | 2013-03-05 | Alembic Ltd. | Process for preparing teriflunomide |
| WO2013113037A1 (en) * | 2012-01-28 | 2013-08-01 | Optmed, Inc. | Improved 1, 1-disubstituted ethylene process |
| US11555011B2 (en) | 2012-01-28 | 2023-01-17 | H.B. Fuller Company | 1,1-disubstituted ethylene process |
Also Published As
| Publication number | Publication date |
|---|---|
| ES2346215T3 (es) | 2010-10-13 |
| CA2519209A1 (en) | 2004-09-30 |
| AR043624A1 (es) | 2005-08-03 |
| EP1606246A1 (de) | 2005-12-21 |
| CA2519209C (en) | 2011-12-06 |
| PL1606246T3 (pl) | 2010-10-29 |
| TW200503995A (en) | 2005-02-01 |
| DK1606246T3 (da) | 2010-09-06 |
| AU2004222139A1 (en) | 2004-09-30 |
| DE10311763A1 (de) | 2004-10-07 |
| CY1110722T1 (el) | 2015-06-10 |
| JP4546952B2 (ja) | 2010-09-22 |
| SI1606246T1 (sl) | 2010-08-31 |
| RU2005132162A (ru) | 2006-02-10 |
| JP2006520345A (ja) | 2006-09-07 |
| CN1756737A (zh) | 2006-04-05 |
| AU2004222139B2 (en) | 2010-03-04 |
| KR101072237B1 (ko) | 2011-10-12 |
| IL170934A (en) | 2009-11-18 |
| PT1606246E (pt) | 2010-07-21 |
| HK1086818A1 (zh) | 2006-09-29 |
| EP1606246B1 (de) | 2010-05-19 |
| DE502004011176D1 (de) | 2010-07-01 |
| CN100361967C (zh) | 2008-01-16 |
| ATE468323T1 (de) | 2010-06-15 |
| KR20050120647A (ko) | 2005-12-22 |
| RU2330838C2 (ru) | 2008-08-10 |
| MXPA05009764A (es) | 2005-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2086944A1 (de) | Verfahren zur herstellung von difluormethylpyrazolylcarboxylaten | |
| EP2285779A1 (de) | Verfahren zur herstellung von arylcarboxamiden | |
| WO1995032952A1 (en) | Process for the preparation of 3-aryluracils | |
| EP3157900B1 (de) | Verfahren zur herstellung von 2-halogenacrylsäureestern | |
| EP2847183B1 (de) | Verfahren zur herstellung von triazol-verbindungen | |
| EP3523270B1 (de) | Verfahren zur herstellung von cyclopropyl-substituierten acetophenonen | |
| DE69105850T2 (de) | Verfahren zur Herstellung von Methoxyiminoacetamidverbindungen und Zwischenverbindungen. | |
| EP1644314B1 (de) | Verfahren zum herstellen von difluoracetessigs urealkylestern | |
| WO2004083165A1 (de) | Verfahren zur hertellung von 2-cyan-3-hydroxy-n-(phenyl)but-2-enamiden | |
| WO2003037868A1 (de) | Verfahren zur herstellung von 2-halogenpyridincarbonsäureamiden | |
| WO2017080770A1 (de) | Synthese von (z)-endoxifenhydrochlorid | |
| EP0370391A2 (de) | Verfahren zur Herstellung von 4,5-Dichlor-6-ethylpyrimidin | |
| DE69518192T2 (de) | Verfahren zur Herstellung von N-Alkyl-N-Pyridinyl-1H-Indol-1-Aminen | |
| DE69417526T2 (de) | Verfahren zur Herstellung von cis-1-Aminoindan-2-ol | |
| DE69328798T2 (de) | Verfahren zur Herstellung von 3-Hydroxymethyl-1-propargyl-imidazolidin-2,4-dion | |
| DE69802176T2 (de) | ein neues verfahren für die Herstellung von 3-N,N-dicyclobutylamino-8-fluoro-3,4-dihydro-2H-1-benzopyran-5-carboxamide | |
| EP1131298B1 (de) | Verfahren zur herstellung von 1-substituierten 5-hydroxypyrazolen | |
| EP1926717B1 (de) | Verfahren zur Herstellung von 3,4-Dichlor-N-(2-cyano-phenyl)-5-isothiazolcarboxamid | |
| EP0720980B1 (de) | Verfahren zur Herstellung von Alkylcarbonsäure-4-Hydroxyaniliden | |
| WO2001036405A1 (de) | Verfahren zur herstellung von benzofuranonoximen | |
| EP1288197A2 (de) | N-unsubstituierte Amidinium-Salze | |
| US6894184B2 (en) | Process for preparing 2-cyano-3-hydroxy-N-(phenyl)but-2-enamides | |
| AT505046A1 (de) | Verfahren zur herstellung von 3,4-disubstituierten phenylessigsäuren, sowie neue zwischenverbindungen | |
| EP3548463B1 (de) | Verfahren zur herstellung von 3-substituierten 2-vinylphenylsulfonaten | |
| RU2315749C1 (ru) | Способ получения 2,4,6-трихлор-3,5-динитроанилина |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| DPEN | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101) | ||
| WWE | Wipo information: entry into national phase |
Ref document number: 2004718192 Country of ref document: EP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 20048058365 Country of ref document: CN |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2519209 Country of ref document: CA Ref document number: PA/a/2005/009764 Country of ref document: MX |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2273/CHENP/2005 Country of ref document: IN |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2004222139 Country of ref document: AU Ref document number: 2006504568 Country of ref document: JP Ref document number: 1020057017413 Country of ref document: KR |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 170934 Country of ref document: IL |
|
| ENP | Entry into the national phase |
Ref document number: 2004222139 Country of ref document: AU Date of ref document: 20040306 Kind code of ref document: A |
|
| WWP | Wipo information: published in national office |
Ref document number: 2004222139 Country of ref document: AU |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2005132162 Country of ref document: RU |
|
| WWP | Wipo information: published in national office |
Ref document number: 2004718192 Country of ref document: EP |
|
| WWP | Wipo information: published in national office |
Ref document number: 1020057017413 Country of ref document: KR |